Robinson; Louise

Patent Applications and Registrations

Patent applications and USPTO patent grants for Robinson; Louise.The latest application filed is for "2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors".

Company Profile

0.14.12

Robinson; Louise - San Carlos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors Grant 8,129,396 - Aurrecoechea , et al. March 6, 2	2012-03-06
Sulfonylethyl phosphorodiamidates Grant 8,093,231 - Allen , et al. January 10, 2	2012-01-10
2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors App 20100081653 - Aurrecoechea; Natalia ; et al.	2010-04-01
Sulfonylethyl Phosphorodiamidates App 20080039429 - Allen; David R. ; et al.	2008-02-14
Antagonists of MCP-1 function and methods of use thereof Grant 7,297,696 - Laborde , et al. November 20, 2	2007-11-20
Sulfonylethyl phosphorodiamidates Grant 7,262,182 - Robinson , et al. August 28, 2	2007-08-28
Tripeptide and tetrapeptide thioethers Grant 7,129,215 - Aurrecoechea , et al. October 31, 2	2006-10-31
Tripeptide And Tetrapeptide Thioethers App 20060160749 - Aurrecoechea; Natalia ; et al.	2006-07-20
Antagonists of MCP-1 function and methods of use thereof Grant 6,998,407 - Laborde , et al. February 14, 2	2006-02-14
Antagonists of MCP-1 function and methods of use thereof Grant 6,992,086 - Laborde , et al. January 31, 2	2006-01-31
Sulfonylethyl phosphorodiamidates App 20050267075 - Allen, David R. ; et al.	2005-12-01
Antagonist of MCP-1 function, and compositions and methods of use thereof Grant 6,962,926 - Laborde , et al. November 8, 2	2005-11-08
Antagonists of MCP-1 function and methods of use thereof App 20050054668 - Laborde, Edgardo ; et al.	2005-03-10
Antagonists of MCP-1 function and methods of use thereof Grant 6,809,113 - Laborde , et al. October 26, 2	2004-10-26
Antagonists of MCP-1 function and methods of use thereof App 20040127513 - Laborde, Edgardo ; et al.	2004-07-01
Antagonists of MCP-1 function and methods of use thereof App 20040077680 - Laborde, Edgardo ; et al.	2004-04-22
Antagonists of MCP-1 function and methods of use thereof Grant 6,677,365 - Laborde , et al. January 13, 2	2004-01-13
Antagonists of MCP-1 function and methods of use thereof Grant 6,670,364 - Laborde , et al. December 30, 2	2003-12-30
Naphthylsulfonic acids and related compounds as glucose uptake agonists Grant 6,653,321 - Spevak , et al. November 25, 2	2003-11-25
Benzene tricarboxylic acid derivatives as insulin receptor activators Grant 6,600,069 - Robinson , et al. July 29, 2	2003-07-29
Antagonists of MCP-1 function and methods of use thereof App 20030105085 - Laborde, Edgardo ; et al.	2003-06-05
Antagonists of MCP-1 function and methods of use thereof App 20030096705 - Laborde, Edgardo ; et al.	2003-05-22
Antagonists of MCP-1 function and methods of use thereof App 20030092728 - Laborde, Edgardo ; et al.	2003-05-15
Substituted diarylureas as stimulators for Fas-mediated apoptosis Grant 6,525,091 - Robinson , et al. February 25, 2	2003-02-25
Substituted Diarylureas As Stimulators For Fas-mediated Apoptosis App 20020188027 - Robinson, Louise ; et al.	2002-12-12
Benzene tricarboxylic acid derivatives as insulin receptor activators App 20020103183 - Robinson, Louise ; et al.	2002-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.